Effects of pulsatile delivery of basal growth hormone on lipolysis in humans

American Journal of Physiology

Volumn 271, Issue 1 PART 1, 1996, Pages

  Cersosimo, Eugenio ^a,b   Danou, Fotini ^a   Persson, Mai ^a   Miles, John M ^a  

^a MAYO CLINIC   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

Fat metabolism; Free fatty acids; Oscillatory secretion; Palmitate; Somatotropin

Indexed keywords

EID: 33745341848     PISSN: 00029513     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Abraham, G. E. Radioassay Systems in Clinical Endocrinology. New York: Dekker, 1981.
2. Belchetz, P., T. Plat, Y. Nakai, E. Keogh, and E. Knobil. Hypophyseal responses to continuous and intermittent delivery of hypothalamic gonadotrophin-releasing hormone. Science Wash. DC 202: 631-633,1978.
3. Cryer, P., and W. Daughaday. Diabetic ketosis-serial plasma growth hormone concentrations during therapy. Diabetes 19: 519-523,1970.
4. Faber, O., C. Binder, J. Markussen, L. Heiding, V. Naithani, H. Kuzuya, P. Blix, D. Horwitz, and A. Rubenstein. Characterization of seven C-peptide antisera. Diabetes 27, Suppl. 1: 170-177, 1978.
5. Ferranini, E., E. Barrett, E. Bevilacqua, and R. DeFronzo. Effect of fatty acids on glucose production and utilization in man. J. Clin. Invest. 72:1737-1747,1983.
6. Goodner, C., B. Walike, D. Koerker, J. Ensinck, A. Brown, E. Chideckerl, J. Palmer, and L. Kalnasy. Insulin, glucagon, and glucose exhibit synchronous sustained oscillations in fasting monkeys. Science Wash. DC 195:177-179,1977.
7. Gyr, K., C. Berlinger, E. Kohler, U. Trautzl, U. Keller, and S. Bloom. Circulating somatostatin: physiological regulator of pancreatic function? J. Clin. Invest. 79:1595-1600,1987.
8. Herbert, V., K. Lau, C. Gottlieb, and S. Bleicher. Cooled charcoal immunoassay of insulin. J. Clin. Endocrinol. Metab. 25: 1375-1384,1965.
9. Jensen, M., M. Caruso, V. Heiling, and J. Miles. Insulin regulation of lipolysis in non-diabetic and IDDM subjects. Diabetes 38: 1595-1601,1989.
10. Jensen, M., V. Heiling, and J. Miles. Measurement of nonsteady-state free fatty acid turnover. Am. J. Physiol. 258 (Endocrinol. Metab. 21): E103-E108,1990.
11. Jensen, M., V. Heiling, and J. Miles. Effects of glucagon on free fatty acid metabolism in humans. J. Clin. Endocrinol. Metab. 72: 308-315,1991.
12. Jensen, M., P. Rogers, M. Ell man, and J. Miles. Choice of infusion-sampling mode for tracer studies of free fatty acid metabolism. Am. J. Physiol 254 (Endocrinol. Metab. 17): E562E565,1988.
13. Keller, U., H. Schnell, J. Girard, and W. Stauffacher. Effect of physiological elevation of plasma growth hormone levels on ketone body kinetics and lipolysis in normal and acutely insulindeficient man. Diabetologia 26: 103-108,1984.
14. Marks, V., N. Howorth, and F. Greenwood. Plasma growth hormone levels in chronic starvation in man. Nature Land. 208: 686-687,1965.
15. Matthews D., B. Naylor, R. Jones, G. Ward, and R. Turner. Pulsatile insulin has greater hypoglycémie effect than continuous delivery. Diabetes 32: 617-621,1983.
16. Miles, J., M. Ellman, K. McClean, and M. Jensen. Validation of a new method for determination of free fatty acid turnover. Am. J. Physiol. 252 (Endocrinol. Metab. 15): E431-E438,1987.
17. Moller, N., P. C. Butler, M. A. Antsiferov, and K. G. M. Albert!. Effects of growth hormone on insulin sensitivity and forearm metabolism in normal man. Diabetologia 32: 105-110, 1989.
18. Paolisso, G., A. Scheen, A. Albert, and P. Lefebvre. Effects of pulsatile delivery of insulin and glucagon in humans. Am. J. Physiol. 257 (Endocrinol. Metab. 20): E686-E696,1989.
19. Quabbe, H. J., E. Schilling, and H. Helge. Pattern of growth hormone secretion during 24-hour fast in normal adults. J. Clin. Endocrinol. Metab. 26:1173-1177,1966.
20. Shaw, J., and R. Wolfe. The integrated effect of adrenergic blockade on glucose, fatty acid and glycerol kinetics: responses in the basal and during hormonal control with somatostatinhormonal infusion. J. Surg. Res. 42: 257-272,1987.
21. Ulloa-Aguirre, A., R. Blizzard, E. Garcia-Rubi, A. Rogol, K. Link, C. Christie, M. Johnson, and J. Veldhuis. Testosterone and oxandrolone, a nonaromatizable androgen, specifically amplify the mass and the rate of growth hormone (GH) secreted per burst without altering GH secretory burst duration or frequency of the GH half-life. J. Clin. Endocrinol. Metab. 71: 846-854,1978.
22. Winer, L., M. Shaw, and G. Bauman. Basal plasma growth hormone levels in man: new evidence for rhythmicity of growth hormone secretion. J. Clin. Endocrinol. Metab. 70: 1678-1686, 1990.